Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

Jiayu Chen(East China University of Science and Technology), Ken H. Young(Duke Medical Center), Karen Dybkær(Aalborg University Hospital), Govind Bhagat(Columbia University Irving Medical Center), Maurilio Ponzoni(San Raffaele University of Rome), Eric D. Hsi(Mayo Clinic), J. Han van Krieken(Radboud University Nijmegen), Zijun Y. Xu‐Monette(Duke University), Attilio Orazi(Texas Tech University), Alexandar Tzankov(University of Basel), Carlo Visco(University of Verona), Azahara Martínez-López(Marqués de Valdecilla University Hospital), Kristy L. Richards(University of North Carolina at Chapel Hill), April Chiu(Mayo Clinic), Lan Pham(The University of Texas MD Anderson Cancer Center), Youli Zu(Methodist Hospital), John P. Farnen(Gundersen Health System), Miguel Á. Piris(Hospital Universitario Fundación Jiménez Díaz), Santiago Montes‐Moreno(Universidad de Cantabria), Ganiraju C. Manyam(The University of Texas MD Anderson Cancer Center), Andrés J.M. Ferreri(Vita-Salute San Raffaele University), Jooryung Huh(Asan Medical Center), Li Zhang(Chongqing Emergency Medical Center), Lihui Yin(The University of Texas MD Anderson Cancer Center), Lijuan Deng(Shandong University of Traditional Chinese Medicine), Xiaoying Zhao(Handan College), Qi Shen(University of Illinois Chicago), Jane N. Winter(Northwestern University), William W.L. Choi(Chinese University of Hong Kong), Michael Møller(Hospital South West Jutland)
Oncotarget
January 21, 2015
Cited by 80


Related Papers